[1]
“SOFT TOPOLOGICAL FRAMEWORK FOR RISK-AWARE DRUG DELIVERY MODELING IN BREAST CANCER WITH PHARMACOKINETIC APPLICATIONS”, Genetics and Mol. Res., May 2026, doi: 10.4238/np2yzk94.